Search Results 21-30 of 10311 for SC

  1. Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in Patients with Dumping Syndrome - Mayo Clinic

    Intra-patient Dose Escalation Study Evaluating Efficacy, Safety and Pharmacokinetics of Pasireotide (SOM230) Subcutaneous (s.c.) Followed by Pasireotide LAR in ...

  2. Khashayarsha Khazaie, Ph.D. - Mayo Clinic Faculty Profiles

    Mayo Clinic researcher Khashayarsha Khazaie (Khash) Ph.D., D.Sc., conducts basic and translational research in cancer immunology and inflammation.

  3. Sickle cell anemia - Diagnosis & treatment - Mayo Clinic

    Learn about the symptoms, causes and treatment of this inherited blood disorder that, in the United States, is more common among Black people.

  4. Publications - Stephanie C. Mavis, M.D., M.H.P.E. - Mayo Clinic

    Mavis SC, Reis CA, Klinkner DB, Stetson RC, Potter DD Jr., Brumbaugh JE. Extravascular migration of a peripherally inserted central catheter into the ...

  5. Matthew R. Augustine, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... South Carolina home. He completed undergrad as well as medical school at the University of South Carolina in Columbia, SC, prior to coming to the Mayo Clinic.

  6. Octreotide (injection route, intramuscular route, subcutaneous route) - Mayo Clinic

    Octreotide injection is used to treat severe diarrhea and other symptoms that occur with certain intestinal tumors (eg, vasoactive intestinal peptide tumors or ...

  7. Rare heart-liver transplant gives South Carolina woman a second chance at life - Mayo Clinic News Network

    Beki Rose and her husband, Tom, had met with half a dozen doctors, and they all said the same thing. "They told me to go home and get my things in order," ...

  8. Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

    Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple ...

  9. Publications - Scott C. Palmer, M.D. - Mayo Clinic

    Palmer SC, Jimenez AA. Peripheral nerve stimulation for treatment of postherpetic neuralgia: A Case report. Acta Medica Academia. 2011; 40(2):187-91. Freeman ...

  10. A Study to Evaluate Whether Participants With Melanoma Prefer Subcutaneous vs Intravenous Administration of Nivolumab and Nivolumab + Relatlimab Fixed-dose Combinations - Mayo Clinic

    About this study. The purpose of this study is to assess the patient's preference for nivolumab subcutaneous (SC) or nivolumab + relatlimab fixed-dose ...